71 related articles for article (PubMed ID: 8017840)
1. Cytotoxicity of CPT-11 and SN-38 for gastrointestinal and recurrent carcinomas cultured on contact-sensitive plates.
Matsuoka H; Furusawa M; Tomoda H; Seo Y; Kono A; Takeda S; Sato K
Anticancer Res; 1994; 14(2A):405-9. PubMed ID: 8017840
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of CPT-11 for gastrointestinal cancer cells cultured on fixed-contact-sensitive plates.
Matsuoka H; Yano K; Seo Y; Saito T; Tomoda H; Takiguchi S; Kono A
Anticancer Drugs; 1995 Jun; 6(3):413-8. PubMed ID: 7670139
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.
Kawato Y; Furuta T; Aonuma M; Yasuoka M; Yokokura T; Matsumoto K
Cancer Chemother Pharmacol; 1991; 28(3):192-8. PubMed ID: 1855276
[TBL] [Abstract][Full Text] [Related]
4. Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.
Fukuda M; Nishio K; Kanzawa F; Ogasawara H; Ishida T; Arioka H; Bojanowski K; Oka M; Saijo N
Cancer Res; 1996 Feb; 56(4):789-93. PubMed ID: 8631015
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11.
Nakatsu S; Kondo S; Kondo Y; Yin D; Peterson JW; Kaakaji R; Morimura T; Kikuchi H; Takeuchi J; Barnett GH
Cancer Chemother Pharmacol; 1997; 39(5):417-23. PubMed ID: 9054955
[TBL] [Abstract][Full Text] [Related]
6. Advantage of combined treatment of CPT-11 and 5-fluorouracil.
Matsuoka H; Yano K; Takiguchi S; Kono A; Seo Y; Saito T; Tomoda H
Anticancer Res; 1995; 15(4):1447-52. PubMed ID: 7654033
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan.
Nakajima TE; Yanagihara K; Takigahira M; Yasunaga M; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Mihara K; Ochiya T; Matsumura Y
Cancer Res; 2008 Nov; 68(22):9318-22. PubMed ID: 19010905
[TBL] [Abstract][Full Text] [Related]
8. In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer.
Tsunoda T; Tanimura H; Hotta T; Tani M; Iwahashi M; Ishimoto K; Tanaka H; Matsuda K; Yamaue H
J Surg Oncol; 2000 Jan; 73(1):6-11. PubMed ID: 10649271
[TBL] [Abstract][Full Text] [Related]
9. Sequence-dependent modulation of anticancer drug activities by 7-ethyl-10-hydroxycamptothecin in an HST-1 human squamous carcinoma cell line.
Masumoto N; Nakano S; Esaki T; Tatsumoto T; Fujishima H; Baba E; Nakamura M; Niho Y
Anticancer Res; 1995; 15(2):405-9. PubMed ID: 7763013
[TBL] [Abstract][Full Text] [Related]
10. Effective conversion of irinotecan to SN-38 after intratumoral drug delivery to an intracranial murine glioma model in vivo. Laboratory investigation.
Wang W; Ghandi A; Liebes L; Louie SG; Hofman FM; Schönthal AH; Chen TC
J Neurosurg; 2011 Mar; 114(3):689-94. PubMed ID: 20415520
[TBL] [Abstract][Full Text] [Related]
11. Intracellular conversion of irinotecan to its active form, SN-38, by native carboxylesterase in human non-small cell lung cancer.
Ohtsuka K; Inoue S; Kameyama M; Kanetoshi A; Fujimoto T; Takaoka K; Araya Y; Shida A
Lung Cancer; 2003 Aug; 41(2):187-98. PubMed ID: 12871782
[TBL] [Abstract][Full Text] [Related]
12. Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells.
Osaki S; Nakanishi Y; Takayama K; Pei XH; Ueno H; Hara N
Cancer Gene Ther; 2000 Feb; 7(2):300-7. PubMed ID: 10770640
[TBL] [Abstract][Full Text] [Related]
13. [Cytotoxic effect of CPT-11 against human recurrent carcinoma cells primarily cultured on contact-sensitive plates: preliminary report].
Matsuoka H; Abe R; Ueo H; Akiyoshi T; Furusawa M; Yamamoto M; Sugimachi K
Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1451. PubMed ID: 1448053
[No Abstract] [Full Text] [Related]
14. [Antitumor effect of SN-38, active form of CPT-11, on human colorectal cancer cell line].
Aiba K; Funakoshi S; Mizunuma N; Dobashi N; Hirano A; Sano M; Kuraishi Y; Kamada M; Ohno N; Sugimoto Y
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1601-6. PubMed ID: 8060134
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance.
Kanzawa F; Sugimoto Y; Minato K; Kasahara K; Bungo M; Nakagawa K; Fujiwara Y; Liu LF; Saijo N
Cancer Res; 1990 Sep; 50(18):5919-24. PubMed ID: 2168285
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of fresh ovarian carcinoma specimens to CPT-11 (irinotecan).
O'meara AT; Sevin BU
Gynecol Oncol; 1999 Feb; 72(2):143-7. PubMed ID: 10021292
[TBL] [Abstract][Full Text] [Related]
17. Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.
Pei XH; Nakanishi Y; Takayama K; Bai F; Kawasaki M; Tsuruta N; Mizuno K; Hara N
Anticancer Drugs; 1997 Mar; 8(3):231-7. PubMed ID: 9095327
[TBL] [Abstract][Full Text] [Related]
18. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
Kawato Y; Aonuma M; Hirota Y; Kuga H; Sato K
Cancer Res; 1991 Aug; 51(16):4187-91. PubMed ID: 1651156
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse.
Kaneda N; Nagata H; Furuta T; Yokokura T
Cancer Res; 1990 Mar; 50(6):1715-20. PubMed ID: 2306725
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of β-glucuronidase in tumors.
Huang PT; Chen KC; Prijovich ZM; Cheng TL; Leu YL; Roffler SR
Cancer Gene Ther; 2011 Jun; 18(6):381-9. PubMed ID: 21350582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
